| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10070500 | European Journal of Surgical Oncology (EJSO) | 2005 | 9 Pages |
Abstract
A staging system that combines tumour factors, sensitive tumour marker(s) and hepatic function is the best predictor of prognosis of HCC patients.
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
A. Nanashima, K. Omagari, S. Tobinaga, K. Shibata, Y. Sumida, M. Mine, S. Morino, S. Shibasaki, N. Ide, H. Shindou, T. Nagayasu,